Clinical Trial

Adjuvant Radiotherapy in Breast With Intensity Modulated by Tomotherapy:

Study acronym: TOMOBREAST
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
Adjuvant radiotherapy after lumpectomy allows a local long-term control of the order 85 to 95% with a survival rate equivalent to that of the totally mastectomy. The diminution of the local recurrence rate after irradiation post- lumpectomy is also associated to a best global survival than only the surgery. The adjuvant radiotherapy after partially or totally mastectomy for the progressive tumors is a therapeutic standard (Early Breast Cancer Trialists' Collaborative Group 2011). The aim of our trial of routine care is to record our practices under this breast adjuvant radiotherapy.
Protocol Amendment History 9 amendments
This ClinicalTrials.gov record has been amended 9 times since 2014-10-31; most recent amendment 2026-03-16.
Status change: Recruiting → Active, Not Recruiting 2021-10-19
Status change: Not Yet Recruiting → Recruiting 2014-12-05
Trial Details
NCT Number NCT02281149
Lead Sponsor Centre Oscar Lambret
Conditions Breast Cancer
Enrollment 500 participants
Start Date 2014-11-18
Primary Completion 2022-12-31 (estimated)
Study Completion 2026-03-31 (estimated)
Updated on ClinicalTrials.gov 2026-03-17